These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 21563925)

  • 1. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q; Su H; Cui J; Wang B
    Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of TGF-β(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo.
    Tu CX; Jin WW; Lin M; Wang ZH; Man MQ
    Arch Dermatol Res; 2011 Nov; 303(9):685-9. PubMed ID: 21644048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
    Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
    Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus.
    Henriques A; Inês L; Couto M; Pedreiro S; Santos C; Magalhães M; Santos P; Velada I; Almeida A; Carvalheiro T; Laranjeira P; Morgado JM; Pais ML; da Silva JA; Paiva A
    Cell Immunol; 2010; 264(1):97-103. PubMed ID: 20553755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells in patients with systemic lupus erythematosus.
    Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R
    J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH; Anderson M; Le E; La Cava A
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.
    Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q
    Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
    Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
    Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis.
    Xing Q; Wang B; Su H; Cui J; Li J
    Rheumatol Int; 2012 Apr; 32(4):949-58. PubMed ID: 21243492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X; Li B; Ye H; Long D
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
    Sharabi A; Lapter S; Mozes E
    J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.
    Franz B; Fritzsching B; Riehl A; Oberle N; Klemke CD; Sykora J; Quick S; Stumpf C; Hartmann M; Enk A; Ruzicka T; Krammer PH; Suri-Payer E; Kuhn A
    Arthritis Rheum; 2007 Jun; 56(6):1910-20. PubMed ID: 17530636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
    Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.